IRF3 and inflammatory bowel disease: These 14 IRF3’s target DEGs, which are not present in SYSCID map and are not currently associated with IBD, are known to be involved in antiviral defence, regulation of cell cycle transition and immune cell migration according to annotations from the Gene Ontology (GO) database (20, 21).